突触可塑性的调节机制及其与神经系统疾病关系的研究进展

doi:10.3760/cma.j.cn441417-20240926-12007

摘要/Abstract

摘要：

突触可塑性的调节机制复杂多样，与神经系统多种疾病密切相关。在众多神经系统退行性疾病和脱髓鞘疾病中，都可发现突触可塑性受损。什么是突触可塑性？突触可塑性受到哪些因素调节？是否可以通过调节突触可塑性来减缓疾病进展、改善预后？本文归纳和总结了突触可塑性的调节机制及其与神经系统疾病的关系，以及寻求新的治疗靶点及可能的机制进行治疗。

关键词: 突触可塑性, 小胶质细胞, 氧化应激, 神经炎症, 进展

Abstract:

The regulatory mechanisms of synaptic plasticity are complex and diverse, and are closely related to many diseases of the nervous system. Impaired synaptic plasticity is found in many neurodegenerative and demyelinating diseases. What is synaptic plasticity? Which factors regulate synaptic plasticity? Can we slow down the progression of the diseases and improve the prognosis regulating synaptic plasticity? In this review, we summarize the regulatory mechanisms of synaptic plasticity and its relationship with nervous system diseases, and explore new therapeutic targets and possible mechanisms for treatment.

Key words: Synaptic plasticity, , Microglia, , Oxidative stress, , Neuroinflammation, , Progress

汪临华霍颖倩李婷婷刘晏民席娅琳王美玲. 突触可塑性的调节机制及其与神经系统疾病关系的研究进展 [J]. 国际医药卫生导报, 2025, 31(12): 1968-1971.

Wang Linhua, Huo Yingqian, Li Tingting, Liu Yanmin, Xi Yalin, Wang Meiling.

Research progress on regulation mechanisms of synaptic plasticity and its relationship with nervous system diseases [J]. International Medicine and Health Guidance News, 2025, 31(12): 1968-1971.

参考文献

[1]Chistiakova M, Bannon NM, Bazhenov M, et al. Heterosynaptic plasticity: multiple mechanisms and multiple roles[J]. Neuroscientist, 2014,20(5):483-498. DOI: 10.1177/1073858414529829.

[2]Park JM, Jung SC, Eun SY. Long-term synaptic plasticity: circuit perturbation and stabilization[J]. Korean J Physiol Pharmacol, 2014,18(6):457-460. DOI: 10.4196/kjpp.2014.18.6.457.

[3]Honkura N, Matsuzaki M, Noguchi J, et al. The subspine organization of actin fibers regulates the structure and plasticity of dendritic spines[J]. Neuron, 2008,57(5):719-729. DOI: 10.1016/j.neuron.2008.01.013.

[4]Kapitein LC, Yau KW, Gouveia SM, et al. NMDA receptor activation suppresses microtubule growth and spine entry[J]. J Neurosci, 2011,31(22):8194-8209. DOI: 10.1523/JNEUROSCI.6215-10.2011.

[5]Hu X, Ballo L, Pietila L, et al. BDNF-induced increase of PSD-95 in dendritic spines requires dynamic microtubule invasions[J]. J Neurosci, 2011,31(43):15597-15603. DOI: 10.1523/JNEUROSCI.2445-11.2011.

[6]Liu YJ, Spangenberg EE, Tang B, et al. Microglia elimination increases neural circuit connectivity and activity in adult mouse cortex[J]. J Neurosci, 2021,41(6):1274-1287. DOI: 10.1523/JNEUROSCI.2140-20.2020.

[7]Stevens B, Allen NJ, Vazquez LE, et al. The classical complement cascade mediates CNS synapse elimination[J]. Cell, 2007,131(6):1164-1178. DOI: 10.1016/j.cell.2007.10.036.

[8]Vainchtein ID, Chin G, Cho FS, et al. Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development[J]. Science, 2018,359(6381):1269-1273. DOI: 10.1126/science.aal3589.

[9]Rauti R, Cellot G, D'Andrea P, et al. BDNF impact on synaptic dynamics: extra or intracellular long-term release differently regulates cultured hippocampal synapses[J]. Mol Brain, 2020,13(1):43. DOI: 10.1186/s13041-020-00582-9.

[10]Tang Y, Le W. Differential roles of M1 and M2 microglia in neurodegenerative diseases[J]. Mol Neurobiol, 2016,53(2):1181-1194. DOI: 10.1007/s12035-014-9070-5.

[11]Wang CS, Kavalali ET, Monteggia LM. BDNF signaling in context: from synaptic regulation to psychiatric disorders[J]. Cell, 2022,185(1):62-76. DOI: 10.1016/j.cell.2021.12.003.

[12]Saw G, Krishna K, Gupta N, et al. Epigenetic regulation of microglial phosphatidylinositol 3-kinase pathway involved in long-term potentiation and synaptic plasticity in rats[J]. Glia, 2020,68(3):656-669. DOI: 10.1002/glia.23748.

[13]Cheng Q, Song SH, Augustine GJ. Calcium-dependent and synapsin-dependent pathways for the presynaptic actions of BDNF[J]. Front Cell Neurosci, 2017,11:75. DOI: 10.3389/fncel.2017.00075.

[14]Gideons ES, Lin PY, Mahgoub M, et al. Chronic lithium treatment elicits its antimanic effects via BDNF-TrkB dependent synaptic downscaling[J]. Elife, 2017,6:e25480. DOI: 10.7554/eLife.25480.

[15]Lalo U, Bogdanov A, Moss GW, et al. Astroglia-derived BDNF and MSK-1 mediate experience- and diet-dependent synaptic plasticity[J]. Brain Sci, 2020,10(7):462. DOI: 10.3390/brainsci10070462.

[16]Horvath PM, Chanaday NL, Alten B, et al. A subthreshold synaptic mechanism regulating BDNF expression and resting synaptic strength[J].Cell Rep, 2021, 36(5):109467.DOI:10.1016/j.celrep.2021.109467.

[17]Gurevich EV, Gainetdinov RR, Gurevich VV. G protein-coupled receptor kinases as regulators of dopamine receptor functions[J]. Pharmacol Res, 2016,111:1-16. DOI: 10.1016/j.phrs.2016.05.010.

[18]Zhou Y, Danbolt NC. Glutamate as a neurotransmitter in the healthy brain[J]. J Neural Transm (Vienna), 2014,121(8):799-817. DOI: 10.1007/s00702-014-1180-8.

[19]Larsen RS, Rao D, Manis PB, et al. STDP in the developing sensory neocortex[J]. Front Synaptic Neurosci, 2010,2:9. DOI: 10.3389/fnsyn.2010.00009.

[20]Czarnecki A, Birtoli B, Ulrich D. Cellular mechanisms of burst firing-mediated long-term depression in rat neocortical pyramidal cells[J]. J Physiol, 2007,578(Pt 2):471-479. DOI: 10.1113/jphysiol.2006.123588.

[21]Larsen RS, Sjöström PJ. Synapse-type-specific plasticity in local circuits[J]. Curr Opin Neurobiol, 2015,35:127-135. DOI: 10.1016/j.conb.2015.08.001.

[22]Davies DA, Adlimoghaddam A, Albensi BC. Role of Nrf2 in synaptic plasticity and memory in Alzheimer's disease[J]. Cells, 2021,10(8):1884. DOI: 10.3390/cells10081884.

[23]Le Douce J, Maugard M, Veran J, et al. Impairment of glycolysis-derived l-serine production in astrocytes contributes to cognitive deficits in Alzheimer's disease[J]. Cell Metab, 2020,31(3):503-517.e8. DOI: 10.1016/j.cmet.2020.02.004.

[24]Wang Y, Fu WY, Cheung K, et al. Astrocyte-secreted IL-33 mediates homeostatic synaptic plasticity in the adult hippocampus[J]. Proc Natl Acad Sci U S A, 2021,118(1):e2020810118. DOI: 10.1073/pnas.2020810118.

[25]Thiele SL, Chen B, Lo C, et al. Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models[J]. Neurobiol Dis, 2014,71:334-344. DOI: 10.1016/j.nbd.2014.08.006.

[26]University of California, San Francisco MS-EPIC Team. Long-term evolution of multiple sclerosis disability in the treatment era[J]. Ann Neurol, 2016,80(4):499-510. DOI: 10.1002/ana.24747.

[27]Di Filippo M, Mancini A, Bellingacci L, et al. Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis[J]. Cell Rep, 2021,37(10):110094. DOI: 10.1016/j.celrep.2021.110094.

[28]Lassmann H, van Horssen J. Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions[J]. Biochim Biophys Acta, 2016,1862(3):506-510. DOI: 10.1016/j.bbadis.2015.09.018.

[29]Palma FR, He C, Danes JM, et al. Mitochondrial superoxide dismutase: what the established, the intriguing, and the novel reveal about a key cellular redox switch[J]. Antioxid Redox Signal, 2020,32(10):701-714. DOI: 10.1089/ars.2019.7962.

[30]de Curtis M, Garbelli R, Uva L. A hypothesis for the role of axon demyelination in seizure generation[J]. Epilepsia, 2021,62(3):583-595. DOI: 10.1111/epi.16824.

[31]Wang P, Ma K, Yang L, et al. Predicting signaling pathways regulating demyelination in a rat model of lithium-pilocarpine-induced acute epilepsy: a proteomics study[J]. Int J Biol Macromol, 2021,193(Pt B):1457-1470. DOI: 10.1016/j.ijbiomac.2021.10.209.

[32]Vinet J, Vainchtein ID, Spano C, et al. Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticus[J]. Glia, 2016,64(8):1350-1362. DOI: 10.1002/glia.23008.

[33]Cho K. Emerging roles of complement protein C1q in neurodegeneration[J]. Aging Dis, 2019,10(3):652-663. DOI: 10.14336/AD.2019.0118.

[34]Sellgren CM, Gracias J, Watmuff B, et al. Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning[J]. Nat Neurosci, 2019,22(3):374-385. DOI: 10.1038/s41593-018-0334-7.

[35]Lepeta K, Kaczmarek L. Matrix metalloproteinase-9 as a novel player in synaptic plasticity and schizophrenia[J]. Schizophr Bull, 2015,41(5):1003-1009. DOI: 10.1093/schbul/sbv036.

[36]Bartsch JC, Schott BH, Behr J. Hippocampal dysfunction in schizophrenia and aberrant hippocampal synaptic plasticity in rodent model psychosis: a selective review[J]. Pharmacopsychiatry, 2023,56(2):57-63. DOI: 10.1055/a-0960-9846.

[37]Mould AW, Hall NA, Milosevic I, et al. Targeting synaptic plasticity in schizophrenia: insights from genomic studies[J]. Trends Mol Med, 2021,27(11):1022-1032. DOI: 10.1016/j.molmed.2021.07.014.